Experimental Therapeutics Clinical Fellowship – National Cancer Centre Singapore
This 12-month fellowship provides comprehensive training in early-phase (Phase I) oncology trials and drug development. Fellows will gain hands-on experience in managing patients enrolled in first-in-human studies and be immersed in precision oncology, translational research, clinical trial design, and multidisciplinary care. The program also focuses on teaching and psycho-social care of patients.
Eligibility Criteria:
-
MBBS and registration as a medical doctor in home country
-
Proficient in English
-
Completed basic training in Internal Medicine; MRCP or local equivalent preferred
-
Preferred: Enrollment in medical oncology training and interest in translational research
-
Not out of clinical practice for more than 3 years
-
For the funded Phase I/Thoracic Fellowship, candidates must be eligible for a medical license in Singapore and show interest in drug development and thoracic oncology
Funding Details:
-
One funded fellowship position is available annually at the Experimental Cancer Therapeutics Unit
-
Support includes research training, clinical exposure, and potential engagement with international trialists and industry
Duration: 12 months
Deadline: Rolling applications (subject to availability and selection)
Further Information:
Email: [email protected]
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023